Komodo Through the Years
Take a scroll through the timeline for some of our most memorable moments!
A New View of Healthcare: MapExplorer™
Our latest innovation revolutionizes market insight generation with its no-code workflow, delivering swift, high-level insights into patient, HCP, HCO, and payer dynamics. Enhanced by MapAI's natural language capabilities, it provides rapid, actionable insights, all powered by Komodo’s comprehensive Healthcare Map.
Read more about MapExplorer
Expanding MapLab: MapAI™
MapAI leverages NLP-based generative AI to streamline insight generation, enabling users of all expertise levels to easily access and analyze healthcare data. Our new innovative tool transforms the MapLab experience by allowing users to pose natural language questions for quick, actionable business or research insights.
Learn more about MapAI
Seeing the Unseen: National Drug Projections
The first in our suite of offerings supporting Projections, Komodo National Drug Projections delivers an all-in-one view of both observed events and projected estimates — with confidence intervals — and enables you to view combined medical and pharmacy benefit estimates and aggregate outputs based on your market dynamics.
Read more about Projections
The First Integrated Patient Insurance Dataset
Komodo Patient Insurance (KPI), is a first-of-its-kind data offering and provides the most comprehensive view of a patient's pharmacy and medical insurance enrollment status, including primary and secondary payer details across channel, segment, payer, and geography.
Learn more about KPI
The One Day Summit 2024
Our 2024 One Day Summit brought together nearly 200 industry leaders to explore the transformative power of data and AI in healthcare, highlighting Komodo's innovative AI-powered platform and its pivotal role in driving the future of data intelligence.
Watch the Summit On-Demand
MapView™: Komodo's Self-Service Analytics Solution
MapView is the industry’s first and most sophisticated analytics application that allows users without data science expertise to easily extract insights from Komodo’s Healthcare Map.
Learn more about MapView
A Look Into Healthcare: The First Komodo Industry Report on Data Challenges
In early 2024, we published a groundbreaking industry-benchmark survey in collaboration with Frost & Sullivan, highlighting the complexities and opportunities in leveraging real-world data for Life Sciences.
Read the Study
2023
Introduction of MapLab™
The milestone launch of MapLab, a comprehensive technology solution for generating enterprise healthcare insights, reinforces Komodo's commitment to transforming healthcare through advanced data science.
Learn more about MapLab
First Annual One Day Summit
In September 2023, we convened our first annual One Day Summit, bringing together Life Sciences leaders, industry influencers, data scientists, and healthcare experts to discuss the future of healthcare.
Expanding the Map with MapEnhance
MapEnhance seamlessly connects a network of specialty data partners to extend the insight-generating capacity of the Healthcare Map.
Learn more about MapEnhance
Awarded CMS Innovator's License
Enhancing the quality of data within our Healthcare Map, the prestigious Innovator’s License from the Centers for Medicare & Medicaid Services (CMS) provides unmatched insights into the patient journey. This advancement offers significant benefits for the healthcare and Life Sciences sectors, delivering a comprehensive view of patient interactions.
Read our white paper
Introducing Measurement by Komodo
Measurement by Komodo helps Life Sciences companies maximize the reach and efficiency of marketing campaigns with a flexible, easy-to-use environment.
2022
Joining the White House Cancer Moonshot
We joined forces with advocacy leaders and public health institutions at the White House to illuminate critical insights to better address gaps in care. With a commitment to democratizing access to patient-level insights and leveraging real-world evidence, we continue to support the Moonshot Initiative in its work to transform cancer care in underserved communities.
Download the research presented at the White House
Chan Zuckerberg Rare as One Partnership
The Chan Zuckerberg Initiative’s Rare as One Network now has access to the Healthcare Map, advancing rare disease research and enhancing diagnostic precision. This collaboration equips patient advocacy organizations with the tools to identify patient cohorts, understand care gaps, and connect patients to essential healthcare resources, driving progress in some of the world's most challenging diseases.
Learn more about how Komodo is finding solutions for rare disease patients
Top 100 Healthcare Technology Companies
The Healthcare Technology Report recognized Komodo in the "Software and Data" category, marking our leadership in pioneering innovative tools to solve challenges across the healthcare enterprise.
Read the full report
2021
Acquisition of Mavens
In early 2021, we welcomed Mavens, integrating their robust cloud-based solutions into our suite of offerings to streamline patient and healthcare provider engagement.
Learn more about Professional Services
Series E Funding
In March, 2021 Komodo announced a $220 million Series E funding round led by Tiger Global and joined by Casdin Capital, which underscored our rapidly growing role as a foundational enterprise technology platform.
Read the press release about our Series E funding round
Acquisition of Breakaway Partners
With our acquisition of Breakaway Partners, we created the first enterprise market access solution combining robust real-world patient data with comprehensive insights on formulary and prescription policies.
Learn more about Komodo’s Market Access solutions
2020
Series C Funding
Led by Andreessen Horowitz and joined by Oak HC/FT, Komodo secured $50 million in Series C funding, enabling the expansion of Komodo's end-to-end analytics platform and building confidence in our vision.
Read the press release about our Series C funding round
2020 Digital Health 150
Komodo was named in CB Insight's second annual Digital Health 150 ranking, which recognized Komodo for its achievements in software and analytics, powering innovation across health systems.
Read the full story
2019
Launch of Prism
Prism, powered by our Healthcare Map, enables teams to test hypotheses, form precise patient cohorts, and generate insightful reports and visualizations, all without the need for coding.
Launch of Iris
Our second product in 2019, Iris is our cutting-edge solution that enables precise strategy optimization and helps drive therapy adoption through comprehensive market analysis and decision-maker identification.
Launch of Sentinel
Sentinel, the third product launched in 2019, is our industry-leading data analytics solution that facilitates the integration of proprietary datasets and tools, helping generate powerful insights within a HIPAA-compliant environment to empower success in today's complex healthcare market.
Learn more about Sentinel
2018
Launch of Pulse
With the launch of Pulse, we developed a pioneering alerting tool that identifies critical intervention opportunities, empowering field teams to engage with clinicians and enhance patient care through timely trials and therapies.
2017
Launch of the Healthcare Map
The Healthcare Map is the industry’s most complete and accurate database of de-identified real-world patient data, enabling a comprehensive understanding of patient journeys.
Learn more about the Healthcare Map
Komodo Becomes a CMS Qualified Entity
Komodo Health has been certified under the CMS Qualified Entity program since 2017. During its tenure, Komodo has been systematically evaluating health system performance, access to care, and effectiveness in healthcare delivery across the entire payer landscape.
Read Komodo’s QE Reports
Inaugural Komodo Week
In what later became a cherished tradition, we brought together all our employees in one central location for the first-ever Komodo Week! A week dedicated to learning, collaborating, and shaping the future of Komodo.
2016
First Komodo Affinity Group: Komodo Cares
Komodo Cares was launched with a mission to use philanthropic investments, employee engagement, and technology to help like-minded organizations and give back to our communities. Volunteers engage in ongoing philanthropic events and fundraising initiatives to support nonprofit organizations. Komodo Cares has raised over $300,000 since its inception.
2015
Our First Product, Aperture
Our flagship solution, Aperture, delivers comprehensive insights, enabling Medical Affairs professionals to engage with the most influential healthcare experts and key opinion leaders.
Early Growth
To support our customers on either coast, in 2015 we opened our first two offices in New York and San Francisco. The year also marked our Seed Series — the first official funding round for Komodo Health.
2014
Founding of Komodo Health
Built in a basement and the local library, co-founders Web Sun and Dr. Arif Nathoo founded Komodo with the mission to reduce the burden of disease through data-driven insights and advanced analytics.
click for more
Bringing It to Life
LUNGevity
Dr. Amy Moore, Vice President of Global Engagement and Patient Partnerships at LUNGevity Foundation, explains that while lung cancer is a leading cause of cancer-related deaths, experts tend to be concentrated in academic medical centers on the coasts of the United States and not easily accessible for a large percentage of the patient population. Komodo Health has helped LUNGevity Foundation to create specialist maps based on publications, funding, and clinical activity, allowing LUNGevity to compile a list of providers for patients. This partnership ensures that patients nationwide have access to the knowledge and experts they need to navigate their cancer diagnosis.
Takeda
Komodo Health's collaboration with Takeda is revolutionizing the treatment landscape for rare diseases such as Hunter syndrome. By leveraging Komodo's advanced data science capabilities, Takeda swiftly identified patients eligible for diagnosis and treatment, significantly shortening the usual diagnostic timelines. This partnership enhances provider engagement through real-world data and sophisticated modeling, offering a transformative approach to rare disease management and ensuring that life-saving treatments reach patients more efficiently.
.png)
Cholangiocarcinoma Foundation
Founder and CEO Stacie Lindsey shares how the Cholangiocarcinoma Foundation's groundbreaking partnership with Komodo Health grants unprecedented access to extensive healthcare data, empowering the foundation to enhance treatment strategies for CCA and deliver timely, localized information to patients and providers.
Turquoise Health
Turquoise Health is working with Komodo to enhance healthcare cost transparency by integrating the Healthcare Map into Turquoise's Clear Rates Data Platform. This collaboration allows Turquoise to analyze patient journeys comprehensively, uncovering cost patterns and simplifying payer-provider contracts. By offering insights into healthcare prices and costs through aggregated patient data, the partnership aims to reduce healthcare expenses and empower stakeholders, including patients, with clearer financial expectations.
Raymond A. Wood
Amy Wood, Executive Director of Raymond A. Wood Foundation, explained how real-world evidence is helping to lay the groundwork for a new medical device. The foundation, founded in 2017, is working to create an at-home blood sodium test to alleviate the challenges of frequent hospital visits. Komodo Prism provides access to accurate real-world evidence about the number of people hospitalized with sodium-related conditions, helping the foundation gather data to support the development and commercialization of the sodium meter.
Peer-Reviewed Publications
As the industry's most comprehensive and powerful source of real-world data to power regulatory submission and payer evidence packages, health outcomes analyses, and comparative economic studies, Komodo has published and powered over 100 studies using the Healthcare Map.
Systemic JIA
Luciana Peixoto, a parent advisor of the Systemic JIA Foundation, shares her experience as a parent of a child diagnosed with SJIA. After many attempts at less invasive treatments, her daughter had to undergo an experimental bone marrow transplantation to combat this debilitating disease. Luciana's work with the Systemic JIA Foundation led her to partner with Komodo, and she's currently using Komodo's Prism solution to investigate and better understand the patient journey of these rare-disease pediatric patients.
Meet the Dragons
Our Dragons are at the heart of everything we do. Explore the hexes below to hear from Dragons about what it’s like being a part of Komodo!
